1. Home
  2. STOK vs HIFS Comparison

STOK vs HIFS Comparison

Compare STOK & HIFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • HIFS
  • Stock Information
  • Founded
  • STOK 2014
  • HIFS 1834
  • Country
  • STOK United States
  • HIFS United States
  • Employees
  • STOK N/A
  • HIFS N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • HIFS Major Banks
  • Sector
  • STOK Health Care
  • HIFS Finance
  • Exchange
  • STOK Nasdaq
  • HIFS Nasdaq
  • Market Cap
  • STOK 740.9M
  • HIFS 611.4M
  • IPO Year
  • STOK 2019
  • HIFS N/A
  • Fundamental
  • Price
  • STOK $12.87
  • HIFS $245.10
  • Analyst Decision
  • STOK Strong Buy
  • HIFS
  • Analyst Count
  • STOK 5
  • HIFS 0
  • Target Price
  • STOK $27.75
  • HIFS N/A
  • AVG Volume (30 Days)
  • STOK 763.5K
  • HIFS 60.3K
  • Earning Date
  • STOK 08-06-2025
  • HIFS 07-11-2025
  • Dividend Yield
  • STOK N/A
  • HIFS 1.02%
  • EPS Growth
  • STOK N/A
  • HIFS 63.41
  • EPS
  • STOK 0.88
  • HIFS 15.35
  • Revenue
  • STOK $190,908,000.00
  • HIFS $75,066,000.00
  • Revenue This Year
  • STOK $378.84
  • HIFS N/A
  • Revenue Next Year
  • STOK N/A
  • HIFS N/A
  • P/E Ratio
  • STOK $14.68
  • HIFS $16.04
  • Revenue Growth
  • STOK 2333.81
  • HIFS 37.00
  • 52 Week Low
  • STOK $5.35
  • HIFS $209.71
  • 52 Week High
  • STOK $16.15
  • HIFS $300.00
  • Technical
  • Relative Strength Index (RSI)
  • STOK 55.63
  • HIFS 43.17
  • Support Level
  • STOK $12.25
  • HIFS $244.00
  • Resistance Level
  • STOK $14.99
  • HIFS $250.64
  • Average True Range (ATR)
  • STOK 0.83
  • HIFS 8.40
  • MACD
  • STOK -0.04
  • HIFS -2.70
  • Stochastic Oscillator
  • STOK 36.30
  • HIFS 7.27

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About HIFS Hingham Institution for Savings

Hingham Institution for Savings is a savings bank based in Hingham, Massachusetts, and is involved in the business of residential and commercial real estate mortgage lending and also financial and banking services. The bank's financial services include personal checking accounts, personal mortgages, home equity lines of credit, money market accounts, savings accounts, certificates of deposit, and business checking accounts. Its lending portfolio mainly encompasses commercial real estate, residential owner-occupied real estate, and loans for the construction of residential real estate.

Share on Social Networks: